Skip to main content
Veterinary Medicines

PRIMUCELL FIP, ρινικό εκνέφωμα, εναιώρημα για γάτες

Authorised
  • Feline coronavirus, strain DF2-ts, Live

Product identification

Medicine name:
PRIMUCELL FIP, ρινικό εκνέφωμα, εναιώρημα για γάτες
Active substance:
  • Feline coronavirus, strain DF2-ts, Live
Target species:
  • Cat
Route of administration:
  • Nasal use

Product details

Active substance and strength:
  • Feline coronavirus, strain DF2-ts, Live
    100000.00
    50% cell culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Nasal spray, suspension
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AD02
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Hellas S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pfizer Hellas A.E.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 1417/16-01-1997/K-0101501
Date of authorisation status change: